Article: Advinus identifies 2 NCEs for metabolic disorders.(Disease/Disorder overview)

Advinus identifies 2 NCEs for metabolic disorders

Mumbai, Nov 5 (PTI) Tata group-backed Advinus Therapeutics today said it has in association with Merck identified two new chemical entities for metabolic disorders.

Both Advinus and Merck entered into an agreement in November 2006 to develop clinically validated drug candidates.

Under the terms of agreement, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!